Draft talk:Maria Dorota Majewska

I am a family member of Maria Dorota Majewska. I have made every effort to ensure the article is neutral, follows the Manual of Style, and is supported by reliable secondary sources. Walerus (talk) 03:05, 11 May 2026 (UTC)

Summarize Timeline Top Qs Fact Check

Hello, and thank you for reviewing this draft. I have carefully revised the article after the decline. All claims are now supported by reliable secondary sources, and the tone has been rewritten to follow the neutral, encyclopedic style required by en‑wiki. To improve the draft further, I would be grateful if you could point out 2–3 specific sentences that you consider non‑encyclopedic or promotional. I will correct them immediately. Thank you in advance for your guidance. I responded to you some time ago via “Reply", but - may be - this place here is better.

“Rewrite the draft to remove promotional language: see Words to watch”. “Promotional language: The guideline does not apply to quotations, which should be faithfully reproduced from the original sources. Use facts and attribution”.

Ref. 1 is supporting its summary in my own words.

Ref. 8 is the author’s publication discussed in detail in ref. 9.

Ref. 9 is the source (journal “Science”) of the quotation, which is a part of the comparison of research in this area of neuroscience.

Ref. 10 supports my description of its content. Ref. 11 is an attribution of a quotation, faithfully reproduced from the source.

Ref. 12 (editorial) characterizes Majewska’s research as “Indeed, studies unveiled the fundamental observation that allopregnanolone is a potent modulator of GABA effects at GABAA receptors (Majewska et al., 1986)”. I replaced it with my own words, but I can faithfully provide the quotation itself.

Ref. 13 faithfully quotes the European science journal's Editorial celebrating the 40th anniversary of a discovery by Majewska.

Ref. 14: I provided in my own words the content of the editorial from the official website of the National Institute of Mental Health saying, what impact Majewska’s group had od the development of a new class of antidepressant medications. I could provide the direct quote with very similar content.

Ref. 15 is a faithful quotation from other neurobiologists commenting on the impact of Majewska’s research in neuroscience for psychiatric therapeutics.

Ref. 16 is the FDA's announcement on the first oral depression pill developed on the basis of Majewska team’s discovery.

Ref. 17 is the faithful quotation from the Scientific American about the pill described in refs. 14, 15 and 16. Refs. 19, 20, 21 are documenting the preclinical and clinical research in Poland, which I described absolutely neutrally, I believe, in my own words.

Ref. 22 summarizes in my own words the latest review (2025) of neurosteroid research in psychiatric and neurological disorders, commenting on her research in ASD autism.

Refs. 24 and 25: my own neutral words summarize their content about baclofen drug being approved in France for treatment against alcoholic addiction; ref. 23 describes in my own words, how baclofen became an important addiction drug, after Majewska co-authored a grant proposal with NIH for its investigation and then coauthored the first clinical trial on addicts.commentary: opinions or direct addresses to the reader; I believe have not expressed any personal opinions.

“This draft's references do not show that the subject meets Wikipedia's criteria for inclusion for academics. The draft requires either: evidence that the subject meets any of the specific criteria for academics; or multiple published secondary sources that: provide significant coverage: discuss the subject in detail, not just brief mentions or routine announcements; are reliable: from reputable outlets with editorial oversight; are independent: not connected to the subject, such as interviews, press releases, the subject's own website, or sponsored content”.

Criterion 1: “The person's research has had a significant impact in their scholarly discipline, broadly construed, as demonstrated by independent reliable sources”.

All the above references provided discuss in great detail Majewska’s significant impact on neurosteroid and autism research and on the development of new psychiatric medications.

Criterion 5: “The person has held a distinguished professor appointment at a major institution of higher education and research, a named chair appointment”.

Ref. 2,3 document that she was awarded the Polish state title of professor of medical sciences by the president of Poland.

Ref. 4 documents her position as a holder the Marie Skłodowska Curie Excellence Chair in Neurobiology at the Institute of Psychiatry and Neurology in Warsaw, leading research sponsored by the prestigious international grant from the European Commission (FP7) entitled Neurobiology of Autism: Role of Steroids and Mercury (ASTER), MEXC-CT-2006-042371.

“The most typical way of satisfying Criterion 1 is to show that the academic has been an author of highly cited academic work – either several extremely highly cited scholarly publications or a substantial number of scholarly publications with significant citation rates.”

Bibliometric profiles of Majewska in recognized by Wikipedia bases are in Scopus, Web of Science and PubMed/NIH/iCite. I provided in the Bibliography section the links to the profiles. According to them, Majewska’s averaged citation rates are 142, 120 and 140 citations per publication, respectively. For comparison, the prominent French neuroscientist E.E. Baulieu has in the Web of Science the citation rate of 45 citations per publication. I can explicitly cite this numbers in the text, if needed. Also, in the Web of Science, Majewska is the first (leading) author in 57% of her neurobiology publications. “Please add references that meet these criteria. If none exist, the subject is not yet suitable for Wikipedia.” Please, 1-2 examples of my references which do not meet Wikipedia criteria, so that would know explicitly, what to avoid. Walerus (talk) 20:05, 23 May 2026 (UTC)